Literature DB >> 15660598

Neurocognitive functioning and quality of life among dually diagnosed and non-substance abusing schizophrenia inpatients.

Michael Herman1.   

Abstract

The aim of this study was to compare the domains of intellectual, memory and executive functions of persons with schizophrenia who concurrently have substance abuse disorders (the dually diagnosed) with a group of non-substance-abusing patients with schizophrenia and to ascertain if there were differences between the two groups in their perceptions of quality of life. Neuropsychological and quality of life data of 46 dually diagnosed and 43 non-substance-abusing patients with schizophrenia was analysed retrospectively. All subjects were inpatients of a state psychiatric hospital. Selected subtests of the Wechsler Adult Intelligence Scale-III and the Wechsler Memory Scale-III constituted the intellectual and memory measures whilst the measures of executive functioning were the Stroop Color Word Test, the FAS version of the Controlled Oral Word Association Test, and the Trail Making Test (Trails A & B). Perceptions of quality of life were evaluated using the World Health Organization Quality of Life measure. The two groups did not differentiate on intellectual and memory domains, however, the dually diagnosed showed a significantly better facility with tasks of executive functions. In addition, the dually diagnosed expressed higher levels of satisfaction with their quality of life compared to the non-substance-abusing patients with schizophrenia. These results have implications for interventions.

Entities:  

Mesh:

Year:  2004        PMID: 15660598     DOI: 10.1111/j.1440-0979.2004.00346.x

Source DB:  PubMed          Journal:  Int J Ment Health Nurs        ISSN: 1445-8330            Impact factor:   3.503


  15 in total

1.  Neurocognitive predictors of objective and subjective quality of life in individuals with schizophrenia: a meta-analytic investigation.

Authors:  Arielle W Tolman; Matthew M Kurtz
Journal:  Schizophr Bull       Date:  2010-07-11       Impact factor: 9.306

2.  Neurocognitive functioning of individuals with schizophrenia: using and not using drugs.

Authors:  Amber L Bahorik; Christina E Newhill; Shaun M Eack
Journal:  Schizophr Bull       Date:  2013-07-24       Impact factor: 9.306

3.  Neurocognition, insight into illness and subjective quality-of-life in schizophrenia: what is their relationship?

Authors:  Matthew M Kurtz; Arielle Tolman
Journal:  Schizophr Res       Date:  2011-01-06       Impact factor: 4.939

4.  Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia.

Authors:  Thomas Wobrock; Helmut Sittinger; Bernd Behrendt; Roberto D'Amelio; Peter Falkai; Dieter Caspari
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-11-25       Impact factor: 5.270

5.  Dimensional symptom severity and global cognitive function predict subjective quality of life in patients with schizophrenia and healthy adults.

Authors:  Pamela DeRosse; George C Nitzburg; Melanie Blair; Anil K Malhotra
Journal:  Schizophr Res       Date:  2017-10-19       Impact factor: 4.939

6.  Outcome prediction with a social cognitive battery: a multicenter longitudinal study.

Authors:  Eric Brunet-Gouet; Capucine Decaix-Tisserand; Mathieu Urbach; Nadine Bazin; Bruno Aouizerate; Lore Brunel; Delphine Capdevielle; Isabelle Chereau; Caroline Dubertret; Julien Dubreucq; Guillaume Fond; Christophe Lançon; Sylvain Leignier; Jasmina Mallet; David Misdrahi; Sylvie Pires; Priscille Schneider; Franck Schurhoff; Hanan Yazbek; Anna Zinetti-Bertschy; Christine Passerieux; Paul Roux
Journal:  NPJ Schizophr       Date:  2021-05-26

7.  The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability.

Authors:  Else-Marie Løberg; Siri Helle; Merethe Nygård; Jan Øystein Berle; Rune A Kroken; Erik Johnsen
Journal:  Front Psychiatry       Date:  2014-11-18       Impact factor: 4.157

8.  BRIEF REPORT: THE IMPACT OF ALCOHOL AND CANNABIS MISUSE ON COGNITION AMONG INDIVIDUALS WITH SCHIZOPHRENIA.

Authors:  Amber L Bahorik; Jack R Cornelius; Srihari S Bangalore; Christina E Newhill; Matcheri S Keshavan; Shaun M Eack
Journal:  Schizophr Res Cogn       Date:  2014-09-01

9.  Cannabis use and cognition in schizophrenia.

Authors:  Else-Marie Løberg; Kenneth Hugdahl
Journal:  Front Hum Neurosci       Date:  2009-11-24       Impact factor: 3.169

10.  An FMRI study of the influence of a history of substance abuse on working memory-related brain activation in schizophrenia.

Authors:  Jessica A Wojtalik; Deanna M Barch
Journal:  Front Psychiatry       Date:  2014-01-21       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.